MedPath

Ondansetron versus Acetaminophen for Prevention of Postspinal Anesthesia Shivering in Cesarean Section: A Randmized Controlled Trial

Phase 1
Recruiting
Conditions
Anaesthesia
Registration Number
PACTR202203547348725
Lead Sponsor
Anesthesia department
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
90
Inclusion Criteria

ASA physical status II female patients,
18-40 years old
scheduled for caesarean section under spinal anesthesia.

Exclusion Criteria

fever or hypothermia before the procedure.
History of hypertension, cardiovascular, psychiatric, neurological, endocrine, chest disease, and/or severe renal or hepatic dysfunction .
obese patients (BMI =30 kg/m2)
those who will need intraoperative blood transfusion
those with known allergy to any of this study drugs.
Any contraindication to neuraxial block

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
occurrence of shivering<br>The shivering severity will be graded as: grade 1(piloerection or peripheral cyanosis, but without visible muscle activity), grade 2 (visible muscle activity confined to one muscle group), grade 3(visible muscle activity in more than one muscle group), or grade 4 (gross muscle activity involving the whole body).Any shivering attack with a score >2 will be treated with Meperidine 25 mg IV. Shivering will be analysed for incidence (number of attacks), severity, time to occur after the intrathecal anesthetic, and its response to meperidine administration.
Secondary Outcome Measures
NameTimeMethod
totally received meperidine doses, the time for first postoperative analgesia request, the occurrence of hypotention or bradycardia, the perioperative complications (nausea, vomiting, dry mouth, dizziness, and desaturation).
© Copyright 2025. All Rights Reserved by MedPath